Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NPAT Antikörper (AA 1377-1427)

NPAT Reaktivität: Human WB, IP, IHC (fp) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7453485
  • Target Alle NPAT Antikörper anzeigen
    NPAT (Nuclear Protein, Ataxia-Telangiectasia Locus (NPAT))
    Bindungsspezifität
    • 2
    • 1
    • 1
    AA 1377-1427
    Reaktivität
    • 7
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 4
    • 3
    Kaninchen
    Klonalität
    • 4
    • 3
    Polyklonal
    Konjugat
    • 7
    Dieser NPAT Antikörper ist unkonjugiert
    Applikation
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))
    Verwendungszweck
    Rabbit anti-NPAT Antibody, Affinity Purified
    Homologie
    Mouse
    Aufreinigung
    Affinity Purified
    Immunogen
    between AA 1377 and 1427
    Isotyp
    IgG
    Top Product
    Discover our top product NPAT Primärantikörper
  • Applikationshinweise

    IHC: 1:1,000 - 1:5,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.

    IP: 2 - 5 μg/mg lysate

    WB: 1:2,000 - 1:10,000

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1000 μg/mL
    Buffer
    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Haltbarkeit
    12 months
  • Target
    NPAT (Nuclear Protein, Ataxia-Telangiectasia Locus (NPAT))
    Andere Bezeichnung
    NPAT (NPAT Produkte)
    Synonyme
    NPAT-like antikoerper, im:6901964 antikoerper, DKFZp469B186 antikoerper, 6820401K01 antikoerper, AI427561 antikoerper, BB112559 antikoerper, E14 antikoerper, E14/NPAT antikoerper, p220 antikoerper, nuclear protein, co-activator of histone transcription antikoerper, nuclear protein, coactivator of histone transcription antikoerper, protein NPAT antikoerper, nuclear protein, ataxia-telangiectasia locus antikoerper, nuclear protein in the AT region antikoerper, nuclear protein, ataxia-telangiectasia locus S homeolog antikoerper, Npat antikoerper, NPAT antikoerper, LOC489420 antikoerper, npat antikoerper, LOC100286556 antikoerper, LOC100402032 antikoerper, LOC100480887 antikoerper, LOC100540521 antikoerper, LOC100561473 antikoerper, LOC100627195 antikoerper, npat.S antikoerper
    Hintergrund
    Background: NPAT (nuclear protein of the ataxia telangiectasia mutated locus) is required for progression through the G1 and S phases of the cell cycle and for S phase entry. It activates transcription of the histone H2A, histone H2B, histone H3 and histone H4 genes in conjunction with MIZF. NPAT also positively regulates the ATM, MIZF and PRKDC promoters. Transcriptional activation may be accomplished at least in part by the recruitment of the NuA4 histone acetyltransferase (HAT) complex to target gene promoters [taken from the Universal Protein Resource (UniProt) ww.uniprot.org/uniprot/Q14207].
    Gen-ID
    4863
    NCBI Accession
    NP_002510
    UniProt
    Q14207
Sie sind hier:
Kundenservice